Home 5 Lab Compliance Advisor 5 Federal Court Calls PAMA Rule “Arbitrary,” but Refuses to Strike It Down

Federal Court Calls PAMA Rule “Arbitrary,” but Refuses to Strike It Down

by | Jul 27, 2022

D.C. Circuit Court of Appeals agrees with lab industry that CMS got Medicare lab pricing all wrong, but says it’s unable to intervene.

D.C. Circuit Court of Appeals agrees with lab industry that CMS got Medicare lab pricing all wrong, but says it’s unable to intervene.

This content is Exclusive to Lab Compliance Advisor Subscribers

Subscribe or Log in for Exclusive Access.